Robert P. Kimberly, M.D., has been inducted as president for the Association for Clinical and Translational Science (ACTS), which is the field's preeminent national organization.
Kimberly is an internationally recognized translational scientist with substantial experience in the development and administration of large, multisite and multiple-investigator scientific programs. His research group is interested in the role of genetic factors in the normal function of the immune system and in the development of autoimmune and immune-mediated inflammatory diseases such as systemic lupus erythematosus (SLE) and systemic vasculitis.
The purpose of the Association for Clinical and Translational Science (ACTS) can be broken up into four realms: research, education, advocacy and mentoring. ACTS supports investigations that continually improve team science, integrating multiple disciplines across the full translational science spectrum. ACTS is the academic home for the disciplines of research education, training, and career development for the full spectrum of translational scientists. Additionally, ACTS provides a strong voice to advocate for translational science, clinical research, patient-oriented research, and research education support. Finally, ACTS promotes investigations and dissemination of effective models for mentoring future generations of translational scientists.